Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Related Posts
Farmakis IT, Binder H, Chopard R, Christodoulou KC, Evrenoglou T, Fengler K, Giri J, Hobohm L, Jaber WA, Klok FA, Kocka V, Kroupa J, Kucher[...]
Hu Z, Lee HL, Cao T, Yoshida T, Ma L, Finn JP, Nguyen KL, Christodoulou AG. MoCo + ROVir: Synergy Between Respiratory Motion Compensation and Cardiac Receive[...]
Fonarow GC, Navar AM, Yancy CW. The Cost-Effectiveness Evolution of Cardiovascular Care. JAMA Cardiol. 2026 Feb 4. doi: 10.1001/jamacardio.2025.5240. Epub ahead of print. PMID: 41637084.